Dia-Präsentation von Merck Gesellschaft mbH. Micardis(R) - Micardis Plus(R) - Klinische Wirksamkeit (39 Abbildungen) Übersicht | ||||||||||||||||||
Abbildung 9: Telmisartan - Losartan The superiority of telmisartan over losartan is also evident when a flexible-dosing regimen is employed. This slide shows the results of an 8-week study in 331 patients with mild-to-moderate hypertension.1 Patients were started at the lower dose, with up-titration to the higher dose allowed if seated trough cuff DBP was ≥90 mmHg at Week 4. By Week 8, the reduction in SBP and DBP in the last 6 h of the dosing interval was greater in the telmisartan arm than in the losartan arm. 1. Data on file. Boehringer Ingelheim GmbH. |
Abbildung 9: Telmisartan - Losartan
The superiority of telmisartan over losartan is also evident when a flexible-dosing regimen is employed. This slide shows the results of an 8-week study in 331 patients with mild-to-moderate hypertension.1 Patients were started at the lower dose, with up-titration to the higher dose allowed if seated trough cuff DBP was ≥90 mmHg at Week 4. By Week 8, the reduction in SBP and DBP in the last 6 h of the dosing interval was greater in the telmisartan arm than in the losartan arm. 1. Data on file. Boehringer Ingelheim GmbH. |
